International Conference on Clinical Neuro Chemistry and Diseases

This track focuses on the cellular and molecular pathways involved in neurodegenerative diseases, including the roles of apoptosis and autophagy. Researchers are encouraged to present studies that elucidate the underlying biochemical processes contributing to these conditions.

This session will explore the impact of neurotransmitter systems on mental health disorders, emphasizing the significance of antidepressant supplements. Contributions should address the biochemical interactions and therapeutic implications of these compounds.

This track examines the peripheral immune response and its implications for neurological health, particularly in the context of chronic stress and traumatic brain injury. Presentations should highlight the interplay between immune dysregulation and neuroinflammation.

Focusing on the phenylalanine hydroxylase (PAH) and trans-sulfuration pathways, this session invites discussions on their relevance to neurological disorders. Researchers are encouraged to present innovative findings that enhance understanding of these metabolic routes.

This track will delve into various stimulation techniques, including sensory level and motor level stimulation, and their applications in neurorehabilitation. Contributions should explore the efficacy and mechanisms of these interventions.

This session will cover advancements in digital sampling and high pass filtering techniques used in neurophysiological research. Presenters are invited to share novel methodologies and their implications for understanding brain function.

This track focuses on the effects of chronic stress on neurochemical pathways and brain function. Researchers are encouraged to present studies that investigate the long-term consequences of stress on mental and physical health.

This session will explore the use of NSAIDs and glucocorticoids in managing neuroinflammatory conditions. Presentations should address the mechanisms of action and clinical outcomes associated with these therapeutic agents.

This track will investigate the peripheral neuroanatomy and its relationship with sensory processing and motor function. Contributions should focus on how anatomical structures influence neurological outcomes.

This session will highlight the latest advancements in implantable elements for neurological applications, including their design and functionality. Researchers are invited to discuss the potential benefits and challenges of these technologies.

This track will examine the mechanisms and implications of hyper-sensitivity reactions in the context of neurological diseases. Presentations should focus on the clinical relevance and potential therapeutic targets for managing these reactions.